Selling Sickness

How the World's Biggest Pharmaceutical Companies Are Turning Us All Into Patients

By Ray Moynihan; Alan Cassels
(Nation Books, Paperback, 9781560258568, 254pp.)

Publication Date: June 2006

List Price: $16.95*
* Individual store prices may vary.
Shop Local
Enter your zip code below to find indies closest to you.

Go


Description

Thirty years ago, Henry Gadsden, the head of Merck, one of the world's largest drug companies, told Fortune magazine that he wanted Merck to be more like chewing gum maker Wrigley's. It had long been his dream to make drugs for healthy people so that Merck could "sell to everyone." Gadsden's dream now drives the marketing machinery of the most profitable industry on earth.

Drug companies are systematically working to widen the very boundaries that define illness, and the markets for medication grow ever larger. Mild problems are redefined as serious illness and common complaints are labeled as medical conditions requiring drug treatments. Runny noses are now allergic rhinitis, PMS has become a psychiatric disorder, and hyperactive children have ADD. When it comes to conditions like high cholesterol or low bone density, being "at risk" is sold as a disease.

Selling Sickness reveals how widening the boundaries of illness and lowering the threshold for treatments is creating millions of new patients and billions in new profits, in turn threatening to bankrupt health-care systems all over the world. As more and more of ordinary life becomes medicalized, the industry moves ever closer to Gadsden's dream: "selling to everyone."




About the Author
Ray Moynihan is one of Australia's leading health writers. He has written for a variety of publications, including the Financial Times, the British Medical Journal, and the New England Journal of Medicine. He lives in Sydney.

Alan Cassels is a Canadian researcher and writer who works on drug policy issues.
Indie Bookstore Finder
EBbooks and EReaders
Find great gifts: Signed books
Link to IndieBound






Update Profile